TherapeuticsMD (TXMD) Finished Goods (2012 - 2022)

TherapeuticsMD has reported Finished Goods for 11 years, with the latest figure at $4.5 million in Q3 2022.

• For the quarter ending Q3 2022, Finished Goods rose 42.36% year-over-year to $4.5 million; the trailing twelve-month figure through Sep 2022 stood at $4.5 million (up 42.36% YoY), and the FY2021 full-year result was $2.9 million, down 12.3% from the prior year.
• Finished Goods for Q3 2022 stood at $4.5 million, up from $4.0 million in the prior quarter.
• The five-year high for Finished Goods was $5.0 million in Q3 2019, with the low at $1.6 million in Q1 2018.
• Historically, Finished Goods has averaged $3.4 million across 5 years, with a median of $3.3 million in 2019.
• Annual changes were most pronounced in 2019 — Finished Goods jumped 122.24% — and 2021, when it plunged 41.45%.
• TherapeuticsMD's Finished Goods stood at $2.9 million in 2018, then jumped by 71.09% to $5.0 million in 2019, then plunged by 32.69% to $3.4 million in 2020, then fell by 12.3% to $2.9 million in 2021, then surged by 54.42% to $4.5 million in 2022.
• The last three Finished Goods figures came in at $4.5 million (Q3 2022), $4.0 million (Q2 2022), and $3.3 million (Q1 2022), per Business Quant data.